GLP-1 Support Program
Specialized nutrition counseling for patients on, exploring, or transitioning off GLP-1 medications
Service · Cloud SaaSCompany source
Company profile
About Nourish
Nourish is a telehealth nutrition care platform that connects patients with registered dietitians for insurance-covered virtual counseling. The company addresses chronic disease management through personalized nutrition therapy, serving patients across all 50 states with a network of over 10,000 licensed registered dietitians employed as W-2 workers. Nourish's platform combines one-on-one telehealth appointments with a mobile app that enables messaging between sessions, goal tracking, curated educational content, and meal planning resources. The company focuses on metabolic health conditions including diabetes, obesity, heart disease, gut health disorders, eating disorders, and prenatal nutrition. Nourish partners with health plans, health systems, and employers to provide medical nutrition therapy as a covered benefit, with 94% of patients paying $0 out-of-pocket. The platform takes a measurement-based approach to care, tracking clinical outcomes like A1C reduction, weight loss, cholesterol improvement, and blood pressure management. Nourish also supports patients on GLP-1 medications with specialized protocols to maximize efficacy and minimize side effects. The company recently introduced an outcomes-based pricing model tying fees to performance, and has expanded into AI-powered care coordination and medically tailored meal delivery through its app. Founded to tackle America's chronic disease crisis through accessible nutrition care, Nourish emphasizes evidence-based medical nutrition therapy focused on sustainable behavior change rather than quick fixes.
Company description Nourish official website
Primary marketMetabolic Health & Nutrition
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at Nourish?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- anorexia
- autoimmune conditions
- binge eating disorder
- bulimia
- cancer
- celiac disease
- Crohn's disease
- diabetes
- diverticulitis
- eating disorders
- endometriosis
- fertility
- food allergies
- gastritis
- gastroparesis
- gestational diabetes
- gut health disorders
- heart disease
- high cholesterol
- hypertension
- IBS
- kidney disease
- liver disease
- menopause
- obesity
- pancreatitis
- PCOS
- prediabetes
- prenatal nutrition
- SIBO
Who it serves
- Direct-to-Consumer
- Employers
- Health Plans
- Health Systems
- Payers
Deployment & integration
Cloud Saas deployment with recorded integration context.
Geographic context
MarketsUnited States (all 50 states)
Company sourceOfficial website
Company milestones
Platform expansion
Raised $100M Series C led by Menlo Ventures (total funding $215M), introduced outcomes-based pricing model tying fees to performance, launched AI-native metabolic care platform with AI agents, expanded to 10,000+ RD network, introduced lab testing offering (Nourish Labs), added medically tailored meal delivery through app, published first annual Impact Report (2025)
Partnerships
Recorded partners
- Atomico
- employers
- Future (fitness coaching)
- health plans
- health systems
- Index Ventures
- J.P. Morgan Growth Equity Partners
- Menlo Ventures
- Thrive Capital
- Y Combinator
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
Medically Tailored Meal Delivery
On-demand meal and grocery ordering through the Nourish app
Service · Cloud SaaSCompany source
Nourish Labs
Lab data integration for dietitians to personalize nutrition care
Platform · Cloud SaaSCompany source
Nourish Mobile App
24/7 access to dietitian messaging, session summaries, goal tracking, and curated nutrition content
Software · Cloud SaaSCompany source
Nourish Virtual Nutrition Care Platform
Insurance-covered telehealth nutrition counseling with registered dietitians
Platform · Cloud SaaSCompany source
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
The Intersection of Diet Quality and Ultraprocessed Food Intake: Using Evidence-Based Categories to Characterize Differences in Cardiometabolic Profiles.American journal of public health · Jul 1, 2026
Evaluation of the Yes to Veg! Programme, a Food Systems Approach to Increase Vegetable Exposure and Agency in Pre-School Age Children: A Quasi-Experimental Study.Maternal & child nutrition · Mar 1, 2026
Correction: Domain-Specific Physical Activity and Obesity Risk among Black Men in the United States: Evidence of a Physical Activity Paradox.Journal of racial and ethnic health disparities · Feb 24, 2026
Domain-Specific Physical Activity and Obesity Risk among Black Men in the United States: Evidence of a Physical Activity Paradox.Journal of racial and ethnic health disparities · Jan 5, 2026
Creating user-friendly resources for healthy food retail implementation - a case study.Public health research & practice · Dec 10, 2025
Four pillars of sustainable food services in healthcare: a practical approach for healthcare leadership.BMJ leader · Dec 4, 2025
Clinical validation
Clinical-trial records
No linked records are currently available.
Regulatory
Regulatory records
No linked records are currently available.
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
8% average weight loss
patients not on GLP-1s after 12 months
1.3% A1C reduction
average after 12 months
27 mg/dL LDL cholesterol reduction
average after 12 months
21 mmHg systolic blood pressure reduction
average after 12 months
80% health improvement rate
patients engaged 6-12 months
94% patient satisfaction
would recommend to friend/family
90% goal achievement
after 3 months
2.3x greater weight loss
patients completing 6+ appointments
Aggregate Patient Outcomes
Overall health improvement and patient satisfaction
80% of patients see health improvements in 30 days; 94% would recommend to a friend; 90% achieve progress towards health goals after 3 months
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Updates from Nourish
Recent articles published on Nourish's official website.
07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Metabolic Health & Nutrition
Companies using AI to optimize metabolic health, provide personalized nutrition recommendations, or analyze metabolic responses to food for generally healthy or non-diabetic populations. Emphasizes wellness, performance optimization, and preventive health rather than management of a diagnosed disease.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.